Search clinical trials for: TMC278 LA 600mg intramuscular injection

Total 192 results

ViiV Healthcare
GlaxoSmithKline

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Repeat Dose Administration of Long-Acting GSK1265744 and Long-Acting TMC278 Intramuscular and Subcutaneous Injections in Healthy Adult Subjects

Infection, Human Immunodeficiency Virus

United States
National Institute of Allergy and Infectious Diseases...

Not yet recruiting

CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy

Pregnancy | HIV-1-infection | Postpartum

United States, South Africa
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis

Atopic Dermatitis

China
Chia Tai Tianqing Pharmaceutical Group Nanjing...

Not yet recruiting

A Clinical Study of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps.

Sinusitis

China
AstraZeneca

Completed

A Study to Assess the Pharmacokinetics and Safety of Single Doses of Anifrolumab in Healthy Subjects

Healthy Subjects | Pharmacokinetics | Safety

United States
Medical University of Silesia

Completed

The Platelet-Rich Plasma in the Therapy of Temporomandibular Disorders (PRP/TMD)

Myalgia | Bruxism | Temporomandibular Disorder | PRP

Poland
Royan Institute

Unknown

Intramuscular Transplantation of Muscle Derived Stem Cell and Adipose Derived Mesenchymal Stem Cells in Patients With Facioscapulohumeral Dystrophy (FSHD)

Dystrophy

Iran, Islamic Republic of
GlaxoSmithKline

Completed

Clinical Evaluation of Nelarabine (506U78)in Japanese Patients With Leukemia or Lymphoma

Leukaemia, Lymphoblastic, Acute and Lymphoma, Lymphoblastic

Japan
St Stephens Aids Trust

Completed

Study in Healthy Volunteers of the Safety and Metabolism of Different Doses of the Anti-HIV Drug TMC278LA.

HIV Infection

United Kingdom
The Cleveland Clinic
Novartis

Completed

Canakinumab in Covid-19 Cardiac Injury (The Three C Study)

COVID-19 | SARS-CoV 2

United States
Medicago

Active, not recruiting

Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults

SARS-CoV-2 Infection

United States, Canada, United Kingdom, Argentina, Brazil, Mexico
Janssen Research & Development, LLC

Completed

A Study to Evaluate Safety, Acceptability, Pharmacokinetics, and ex Vivo Pharmacodynamics of TMC278 Long Acting Formulation in HIV-1 Seronegative Participants

Healthy

United States
Chumakov Federal Scientific Center for Research...

Active, not recruiting

Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19 of Children at the Age of 12-17 Years Inclusive"

Vaccine

Russian Federation
Chumakov Federal Scientific Center for Research...

Completed

This is a Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19

Coronavirus Infections | Vaccine

Russian Federation
Federico II University

Completed

Mesoglycan, Vascular Reactivity and Metabolic Syndrome

Metabolic Syndrome

Italy
Heinrich-Heine University, Duesseldorf

Unknown

Novel Therapy of PAD by Combined Transplantation of BMCs

Peripheral Arterial Disease

Germany
Janssen Research & Development, LLC

Active, not recruiting

A Study of a Rilpivirine Extended-Release Suspension in Healthy Participants

Healthy

United States, Netherlands
Crossject

Unknown

Performance Evaluation by Magnetic Resonance Imaging (MRI) of Intramuscular Thigh Injections With 3 Configurations of Needle-free Injector (ZENEO®)

No Condition
Takeda

Completed

Phase 1/2 Study of TAK-850 Subcutaneous Injection in Healthy Adults

Influenza Infection
Tissue Genesis
U.S. Army Medical Research and Development Command

Active, not recruiting

Evaluation of the Tissue Genesis® Icellator Cell Isolation System™ to Treat Critical Limb Ischemia (CLI-DI)

Critical Limb Ischemia

United States
Peking University Third Hospital

Not yet recruiting

Needle-Free Subcutaneous Injector and Conventional Intramuscular Injection of Mecobalamin in Diabetes Peripheral Neuropathy

Diabetic Peripheral Neuropathy
Nanjing University

Recruiting

Umbilical Cord Artery-derived Perivascular Stem Cells for the Critical Limb Ischemia Therapy

Critical Limb Ischemia

China
Pfizer

Active, not recruiting

Special Investigation for Booster Dose of Comirnaty in Children Ages 6 Months Though 4 Years

COVID-19 | SARS-CoV-2

Japan
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Completed

Efficacy and Safety Study of Magnesium Isoglycyrrhizinate Injection in Subjects With Acute Drug-induced Liver Injury

Drug-Induced Liver Injury

China
Crossject

Completed

Performance Thresholds Evaluation by Wet Injection Quantification and Magnetic Resonance Imaging (MRI) of Subcutaneous and Intramuscular Injections (0,65ml) of Several Configurations of Needle-free Devices (ZENEO®)

No Condition
Seventh Medical Center of PLA General Hospital

Active, not recruiting

Evaluate the Safety and Immunogenicity of Ad5 COVID-19 Vaccines for Booster Use in Children Aged 6-17 Years.

COVID-19

China
ModernaTX, Inc.

Completed

Long-Term Follow-up Survey of COVID-19 Vaccine After Vaccination

Coronavirus Disease (COVID-19)

Japan
Takeda

Withdrawn

Survey of the Moderna COVID-19 Vaccine in People at High-Risk of Developing Severe COVID-19 Symptoms

Coronavirus Disease (COVID-19)

Japan
Istituto Nazionale di Ricovero e Cura per Anziani
Regione Marche

Unknown

Study on the Effects of Oxygen-ozone Therapy on Back Pain in Subjects Aged 65 or Older (O2-O3)

Back Pain

Italy
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

Evaluate the Efficacy and Safety of HBM9161(HL161)Subcutaneous Injection in Patients With Generalized MG Patients (MG)

Myasthenia Gravis

China
ViiV Healthcare
GlaxoSmithKline

Completed

Study to Evaluate the Safety Tolerability and Acceptability of Long Acting Injections of the Human Immunodeficiency Virus (HIV) Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR)

Infection, Human Immunodeficiency Virus

United States
Brainstorm-Cell Therapeutics
Hadassah Medical Organization

Completed

Autologous Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

Israel
Wake Forest University Health Sciences

Recruiting

Infracalcaneal Peppering Injection Technique for Chronic Plantar Fasciitis

Chronic Plantar Fasciitis

United States
AnGes, Inc.
Japan Agency for Medical Research and Development

Completed

Phase I/II Study of COVID-19 DNA Vaccine (AG0302-COVID19 High-dose)

COVID-19 Lower Respiratory Infection

Japan
Saglik Bilimleri Universitesi

Completed

Intramuscular Benzathine Penicillin Injection Procedure

Injection Site Discomfort

Turkey
University of Maryland, Baltimore

Completed

Hepatitis B Vaccine in Seniors

Hepatitis B Vaccination

United States
PhytoHealth Corporation

Withdrawn

Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer

Cancer | Fatigue | Surgery

Taiwan
University of Guelph
McMaster University

Recruiting

PKU Carriers Trial (Pilot Study): Impact on Cognition, Mental Health, Blood Pressure and Metabolism

Autosomal Recessive Disorder (Genetic Carriers of PKU)

Canada
Instituto de Investigación Hospital Universitario...
Hospital Universitario La Paz

Completed

Treatment CLI Nonrevascularizable Lower Limb With Cell Therapy (HULPVAS)

Nonrevascularizable Critical Ischemia of the Lower Limbs

Spain
Rockefeller University
Bill and Melinda Gates Foundation; International AIDS Vaccine Initiative; Aaron... and other collaborators

Completed

Study of a Potential Preventive Vaccine Against HIV in Healthy Volunteers (ADVAX-EP)

HIV Infections

United States
Genethon

Completed

Clinical Study of AAV1-gamma-sarcoglycan Gene Therapy for Limb Girdle Muscular Dystrophy Type 2C

Limb Girdle Muscular Dystrophy Type 2C | Gamma-sarcoglycanopathy

France
Harbour BioMed (Guangzhou) Co. Ltd.

Completed

A Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG Patients

Myasthenia Gravis

China
Harbour BioMed (Guangzhou) Co. Ltd.

Not yet recruiting

Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis

Myasthenia Gravis

China
Fluart Innovative Vaccine Ltd, Hungary

Completed

Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and Adolescents

Human Influenza
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Effect of Testosterone on Muscle Fractional Synthetic Rate (MK-0000-064)

Muscle Anabolism
Alvotech Swiss AG

Completed

Comparative Safety, Tolerability, Pharmacokinetic Study of AVT02 (100MG/ML) and Humira (100MG/ML) in Healthy Volunteers (ALVOPAD)

Healthy Volunteers

Australia
Biruni University

Completed

Duration of IM Injection and Pain Intensity

Pain Measurement

Turkey
PhytoHealth Corporation

Recruiting

PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients

Cancer-related Fatigue

Taiwan
Immunomic Therapeutics, Inc.

Completed

A Safety and Immunogenicity Phase I Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid

Allergic Rhinoconjunctivitis

United States
Immunomic Therapeutics, Inc.

Completed

A Safety and Immunogenicity Phase IB Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid Assessing the Long Term Safety of Previously Treated Subjects

Allergic Rhinoconjunctivitis

United States

3

Subscribe